U.S., Sept. 5 -- ClinicalTrials.gov registry received information related to the study (NCT07153731) titled 'The Clinical Research of Traditional Chinese Medicine Compound Formulas' on May 11.
Brief Summary: To observe the efficacy and safety of Shenkangling, a traditional Chinese medicine decoction, for renal ischemia-reperfusion injury, and to provide evidence-based medical evidence and ideas for clinical therapeutic use.
Study Start Date: Oct. 01
Study Type: INTERVENTIONAL
Condition:
Urologic Injuries
Urology
Intervention:
DRUG: Shenkangling
Chinese herbal tonics taken orally: Shenkangling, one dose, 2 times a day, 1 time before breakfast and 1 time 30 minutes after dinner.
Recruitment Status: NOT_YET_RECRUITING
Sponsor: The Fo...